A Novel Engineered VEGF Blocker With an Excellent Pharmacokinetic Profile and Robust Anti-Tumor Activity

BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1140-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Beta-Endorphin - Novel Anti-Tumor Activity

Madridge Journal of Oncogenesis
2019English

In Vitro Anti-Trypanosoma Cruzi Activity of Dronedarone, a Novel Amiodarone Derivative With an Improved Safety Profile

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Construction and Characterization of an Anti-Cd20 mAb Nanocomb With Exceptionally Excellent Lymphoma-Suppressing Activity

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2015English

Identification and Analysis of in Vivo VEGF Downstream Markers Link VEGF Pathway Activity With Efficacy of Anti-Vegf Therapies

Clinical Cancer Research
Cancer ResearchOncology
2013English

In Vitro and in Vivo Anti-Tumor Effects of Brexpiprazole, a Newly-Developed Serotonin-Dopamine Activity Modulator With an Improved Safety Profile

Oncotarget
Oncology
2019English

The Development of Novel Organotin Anti-Tumor Drugs: Structure and Activity

Metal-Based Drugs
1998English

Anti-Tumor Activity of Stability-Engineered IgG-like Bispecific Antibodies Targeting TRAIL-R2 and LTβR

mAbs
AllergyImmunology
2009English

A Novel Robust Disturbance Rejection Anti-Windup Framework

International Journal of Control
ControlSystems EngineeringComputer Science Applications
2011English

Delineating the Effect a Novel Anti-Vegf-A Therapy Has on the Lymphatic System of Immunocompetent Tumor-Bearing Mice

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy